Form 4: Twist Bioscience Officer Sells Shares for Tax Obligations

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 1,693 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp (TWST), reported a transaction on February 23, 2026.
• The transaction involved the sale of 1,693 shares of common stock at a price of $46.7098 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The sale does not represent a discretionary trade by Mr. Werner.
• Following this transaction, Mr. Werner beneficially owns 55,045 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine, non-discretionary transaction for tax purposes related to equity compensation, rather than a reflection of management's sentiment on the stock.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are common for executives receiving equity compensation and are generally not indicative of a change in management's outlook on the company's prospects, distinguishing them from discretionary sales.

Stakeholder Impact

• Shareholders: The sale represents a minor dilution of ownership for tax purposes, but is a standard practice for equity compensation.

Key Dates

Recommendation

The transaction is a routine 'sell to cover' for tax obligations related to RSU vesting and does not reflect a discretionary decision by the Chief Accounting Officer regarding the company's future prospects. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Twist Bioscience, TWST, Insider Trading, Form 4, Stock Sale, Robert F. Werner, Chief Accounting Officer, Restricted Stock Units, Tax Withholding